Neuphoria Therapeutics Inc.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $19.9M | $19.4M | $22.2M | $13.6M | $14.2M | $17.0M | $4.3M | $8.1M |
| Accounts Receivable | $813.4K | $1.6M | $1.1M | $1.8K | $11.9K | $24.6K | $35.6K | $116.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $21.1M | $21.7M | $23.4M | $14.0M | $15.0M | $17.1M | $4.4M | $8.4M |
| Property, Plant & Equipment | — | — | — | $2.6K | $2.8K | $1.6K | $1.7K | $2.0K |
| Goodwill | $3.5M | $8.8M | $8.7M | $8.7M | $8.6M | $8.5M | $8.4M | $8.9M |
| Intangible Assets (Excl. Goodwill) | $4.1M | $4.3M | $4.5M | $4.6M | $4.8M | $5.0M | $5.1M | $5.3M |
| Total Assets | $28.7M | $34.8M | $36.6M | $27.3M | $28.6M | $30.7M | $18.2M | $22.9M |
| Liabilities | ||||||||
| Accounts Payable | $385.6K | $627.2K | $520.7K | $1.4M | $1.2M | $745.3K | $1.5M | $1.3M |
| Total Current Liabilities | $756.6K | $1.5M | $2.6M | $5.1M | $4.2M | $1.6M | $2.1M | $2.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $4.1M | $5.4M | $6.9M | $14.8M | $9.6M | $4.7M | $4.4M | $5.8M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-191.8M | $-186.9M | $-186.4M | $-188.3M | $-178.3M | $-169.5M | $-180.7M | $-178.8M |
| Total Stockholders' Equity | $24.6M | $29.4M | $29.7M | $12.5M | $19.0M | $26.0M | $13.7M | $17.1M |